Familial risk of prostate cancer in Iceland

BJU International

Volumn 92, Issue 9, 2003, Pages 915-919

  Eldon, B J ^a,c   Jonsson, E ^a   Tomasson, J ^a   Tryggvadottir, L ^b   Tulinius, H ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b ICELANDIC CANCER REGISTRY   (Iceland)

^c UVS   (Iceland)

Author keywords

Disease severity; Family history; Prostate cancer

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; FAMILIAL CANCER; FAMILY HISTORY; HUMAN; ICELAND; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; ICELAND; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PEDIGREE; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 0346119094     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2003.04536.x     Document Type: Article

References (34)

1. The Icelandic Cancer Society. Annual Report 2000. Reykjavik: The Icelandic Cancer Society, 2000
2. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality, Int J Cancer 2000; 85: 60-7
3. Møller B, Fekjær H, Hakulinen T et al. Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev 2002; 11 (Suppl. 1): 47-9
4. Rowley KH, Mason MD. The etiology and pathogenesis of prostate cancer. Clin Oncol 1997; 9: 213-8
5. Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Intern Med 1993; 118: 793-803
6. Smith JR, Freije D, Carpten JD et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996; 274: 1371-3
7. Xu J, Meyers D, Freije D et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998; 20: 175-9
8. Gibbs M, Stanford JL, McIndoe RA, Jarvik GP, Kolb S, Goode L. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 1999; 64: 776-87
9. Berthon P, Valeri A, Cohen-Akenine A, Drelon E, Paiss T, Whör G. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet 1998; 62: 1416-24
10. Xu J, Zheng SL, Hawkins GA et al. Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. Am J Hum Genet 2001; 69: 341-50
11. Simard J, Dumont M, Soucy P, Labrie F. Perspective: Prostate cancer susceptibility genes. Endocrinology 2002; 143: 2029-40
12. Hemminki K, Dong C. Familial prostate cancer from the Family-Cancer database. Eur J Cancer 2000; 36: 229-34
13. McCahy PJ, Harris CA, Neal DE. Breast and prostate cancer in the relatives of men with prostate cancer. Br J Urol 1996; 78: 552-6
14. Keetch DW, Rice JP, Suarez BK, Catalona WJ. Familial aspects of prostate cancer: a case control study. J Urol 1995; 154: 2100-2
15. Bjarnason O, Tulinius H. Cancer registration in Iceland 1955-74. Acta Pathol Microbiol Immunol Scand 1983; 91 (Suppl. 281)
16. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol. II. Lyon: IARC, 1987
17. Childs B, Scriver CR. Age at onset and causes of disease. Perspect Biol Med 1986; 29: 437-60
18. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89: 3367-71
19. Grönberg H, Isaacs SD, Smith JR et al. Characteristics of prostate cancer in families potentially linked to the Hereditary Prostate Cancer 1 (HPC1) locus. JAMA 1997; 278: 1251-5
20. Carter BS, Bova GS, Beaty TH et al. Hereditary prostate cancer, epidemiological and clinical features. J Urol 1993; 150: 797-802
21. Pentyala SN, Lee J, Hsieh K et al. Prostate cancer: a comprehensive review. Med Oncol 2000; 17: 85-105
22. Kupelian PA, Kupelian VA, Witte JS, Macklish R, Klein EA. Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome. J Clin Oncol 1997; 15: 1478-80
23. Kupelian PA, Klein EA, Witte JS, Kupelian VA, Suh JH. Familial prostate cancer: a different disease? J Urol 1997; 158: 2197-201
24. Tulinius H, Egilsson V, Ólafsdóttir GH, Sigvaldason H. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. BMJ 1992; 305: 855-7
25. Arason A, Barkardóttir RB, Egilsson V. Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostate cancer. Am J Hum Genet 1993; 52: 711-7
26. Thiessen EU. Considering a familial association between breast cancer and both prostatic and uterine malignancies. Cancer 1974; 34: 1102-7
27. Anderson DE, Badzioch MD. Familial breast cancer risks, effects of prostate and other cancers. Cancer 1993; 72: 114-9
28. Sellers TA, Potter JD, Rich SS et al. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer. J Natl Cancer Inst 1994; 86: 1860-5
29. Tulinius H, Olafsdóttir GH, Sigvaldason H et al. The effects of a single BRCA2 mutation on cancer in Iceland. J Med Genet 2002; 39: 457-62
30. Sigurdsson S, Thorlacius S, Tomasson J et al. BRCA2 mutation in Icelandic prostate cancer patients. J Mol Med 1997; 75: 758-61
31. Edwards SM, Zsofia KJ, Julia M et al. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 2003; 72: 1-12
32. Johannesdóttir G, Gudmundsson J, Bergthorsson JT et al. High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 1996; 56: 3663-5
33. Grönberg H, Bergh A, Damber J, Emanuelsson M. Cancer risk in families with hereditary prostate carcinoma. Cancer 2000; 89: 1315-21
34. Matikainen MP, Pukkala E, Schleutker J et al. Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland. Cancer Causes Control 2001; 12: 223-30